Michael David Golden

USPTO Granted Patents = 8 (Patent Applications = 5)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 10.9

ph-index = 3

Forward Citations = 49(Granted Patents)

Company Filing History:

2 out of 26

Forest Laboratories Holdings Limited

4. 2 out of 832,680

Other

patents

Years Active: 2012-2019

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10344015 - Chemical process for the synthesis of 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline (2019-07-09),

2. 9815816 - Chemical process for the synthesis of 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline (2017-11-14),

3. 9695122 - Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof (2017-07-04),

4. 9284314 - Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof (2016-03-15),

5. 8969566 - Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof (2015-03-03),

6. 8865899 - Chemical process for the synthesis of 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline (2014-10-21),

7. 8829191 - Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof (2014-09-09),

8. 8163926 - Process for the synthesis of piperidinyl sulphonate esters (2012-04-24),

Title: The Innovative Journey of Michael David Golden

Introduction

Michael David Golden, based in Macclesfield, GB, is an esteemed inventor known for his contributions to the field of chemical processes. With a remarkable portfolio of 8 patents, he has established himself as a significant player in the development of quinazoline derivatives, which have potential pharmaceutical applications.

Latest Patents

Among his latest inventions is a patent focused on a chemical process for the synthesis of 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline. This groundbreaking invention involves the processes for manufacturing certain quinazoline derivatives and the intermediates essential for their production. Through innovative chemical processes, Golden has significantly advanced the methodologies for producing these important compounds, aiding in the development of new pharmaceutical products.

Career Highlights

Throughout his career, Michael David Golden has been affiliated with respected organizations such as Forest Laboratories Holdings Limited. His work at these institutions has enabled him to refine his expertise and apply his skills in innovative chemical processes that benefit the pharmaceutical industry and beyond.

Collaborations

Michael has collaborated with talented individuals including Melanie Simone Ronsheim and Saibaba Racha. These partnerships have allowed him to leverage diverse perspectives and methodologies, further enhancing the quality and impact of his inventions.

Conclusion

Michael David Golden's contributions to the field of chemical processes and his extensive patent portfolio highlight his innovative spirit and commitment to advancing science. His work continues to pave the way for new advancements in pharmaceuticals, showcasing the vital role of inventors in shaping our world.

This text is generated by artificial intelligence and may not be accurate.